banda transcan

The previous ERA-NET on translational cancer research TRANSCAN was funded by the European Commission under the FP7 from 2011 to 2014.

The main objective of TRANSCAN was to coordinate national and regional translational cancer research funding organisations' activities, aiming at the integration of basic, clinical and epidemiological cancer research and facilitation of coordinated, transnational cancer funding in Europe with the ultimate aim to streamline EU-wide cancer screening, early diagnosis, prognosis, treatment and care.

The specific objectives of TRANSCAN have been achieved through the implementation of interconnected activities, structured into the following six work packages:

Work Package 1 - Management and network coordination (Leader: MoH-ISS, Italy)
Work Package 2 - Survey and analysis of national cancer research funding of translational cancer research (Leader: CR-UK, United Kingdom)
Work Package 3 - Preparation of joint transnational calls (JTCs) (Leader: ISCIII, Spain)
Work Package 4 - Implementation of joint transnational calls (JTCs) (Leader: DLR, Germany)
Work Package 5 - Implementation of capacity building & training activities (Leader: INCa, France)
Work Package 6 - Monitoring of activities & network sustainability (Leader: FCT, Portugal)

In the frame of TRANSCAN, three Joint Transnational Calls were launched

JTC 2011
JTC 2012
JTC 2013


TRANSCAN-2 News


PRE-ANNOUNCEMENT

The Fourth Joint Transnational Call 2017 (JTC 2017)

will be launched on December 5th, 2017

on: Translational Research on Rare Cancers

The list of participant funding organizations has been updated on November 21st

(FCT - Portugal has joined the call)

visit the page


JTC 2016

on: “Minimally and non-invasive methods for early detection and/or progression of cancer"

14 projects selected for funding 

visit the page


 

Newsletters

Newsletter 3, September 2017

Newsletter 2, April 2017

Newsletter 1, December 2016

 

To subscribe to TRANSCAN-2 newsletter mailing list please send an email to: This email address is being protected from spambots. You need JavaScript enabled to view it.

eu flagship

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643638.

Cookie consent script